Literature DB >> 32765891

Predictors of radiation necrosis in long-term survivors after Gamma Knife stereotactic radiosurgery for brain metastases.

Zaid A Siddiqui1, Bryan S Squires1, Matt D Johnson1, Andrew M Baschnagel1, Peter Y Chen1, Daniel J Krauss1, Ricky E Olson2, Kurt D Meyer1, Inga S Grills1.   

Abstract

BACKGROUND: The long-term risk of necrosis after radiosurgery for brain metastases is uncertain. We aimed to investigate incidence and predictors of radiation necrosis for individuals with more than 1 year of survival after radiosurgery for brain metastases.
METHODS: Patients who had a diagnosis of brain metastases treated between December 2006 and December 2014, who had at least 1 year of survival after first radiosurgery were retrospectively reviewed. Survival was analyzed using the Kaplan-Meier estimator, and the incidence of radiation necrosis was estimated with death or surgical resection as competing risks. Patient and treatment factors associated with radiation necrosis were also analyzed.
RESULTS: A total of 198 patients with 732 lesions were analyzed. Thirty-four lesions required salvage radiosurgery and 10 required salvage surgical resection. Median follow-up was 24 months. The estimated median survival for this population was 25.4 months. The estimated per-lesion incidence of radiation necrosis at 4 years was 6.8%. Medical or surgical therapy was required for 60% of necrosis events. Tumor volume and male sex were significant factors associated with radiation necrosis. The per-lesions incidence of necrosis for patients undergoing repeat radiosurgery was 33.3% at 4 years.
CONCLUSIONS: In this large series of patients undergoing radiosurgery for brain metastases, patients continued to be at risk for radiation necrosis throughout their first 4 years of survival. Repeat radiosurgery of recurrent lesions greatly exacerbates the risk of radiation necrosis, whereas treatment of larger target volumes increases the risk modestly.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  brain metastases; radiation necrosis; radiosurgery; survivorship

Year:  2019        PMID: 32765891      PMCID: PMC7393283          DOI: 10.1093/nop/npz067

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  42 in total

1.  Risk analysis of linear accelerator radiosurgery.

Authors:  J Voges; H Treuer; V Sturm; C Büchner; R Lehrke; M Kocher; S Staar; J Kuchta; R P Müller
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-12-01       Impact factor: 7.038

2.  Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.

Authors:  Jiayi Huang; Ay-Ming Wang; Anil Shetty; Ann H Maitz; Di Yan; Danielle Doyle; Kenneth Richey; Sean Park; Daniel R Pieper; Peter Y Chen; Inga Siiner Grills
Journal:  Magn Reson Imaging       Date:  2011-05-14       Impact factor: 2.546

3.  A randomized trial of surgery in the treatment of single metastases to the brain.

Authors:  R A Patchell; P A Tibbs; J W Walsh; R J Dempsey; Y Maruyama; R J Kryscio; W R Markesbery; J S Macdonald; B Young
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

4.  12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors.

Authors:  Timothy Korytko; Tomas Radivoyevitch; Valdir Colussi; Barry W Wessels; Kunjan Pillai; Robert J Maciunas; Douglas B Einstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-14       Impact factor: 7.038

5.  Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.

Authors:  Jack P Rock; David Hearshen; Lisa Scarpace; David Croteau; Jorge Gutierrez; James L Fisher; Mark L Rosenblum; Tom Mikkelsen
Journal:  Neurosurgery       Date:  2002-10       Impact factor: 4.654

6.  Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

Authors:  Sarah B Goldberg; Scott N Gettinger; Amit Mahajan; Anne C Chiang; Roy S Herbst; Mario Sznol; Apostolos John Tsiouris; Justine Cohen; Alexander Vortmeyer; Lucia Jilaveanu; James Yu; Upendra Hegde; Stephanie Speaker; Matthew Madura; Amanda Ralabate; Angel Rivera; Elin Rowen; Heather Gerrish; Xiaopan Yao; Veronica Chiang; Harriet M Kluger
Journal:  Lancet Oncol       Date:  2016-06-03       Impact factor: 41.316

7.  Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?

Authors:  Rovel J Colaco; Pierre Martin; Harriet M Kluger; James B Yu; Veronica L Chiang
Journal:  J Neurosurg       Date:  2015-11-06       Impact factor: 5.115

8.  Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases.

Authors:  John M Varlotto; John C Flickinger; Ajay Niranjan; Ajay K Bhatnagar; Douglas Kondziolka; L Dale Lunsford
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-10-01       Impact factor: 7.038

9.  Prediction of complications in gamma knife radiosurgery of arteriovenous malformation.

Authors:  I Lax; B Karlsson
Journal:  Acta Oncol       Date:  1996       Impact factor: 4.089

10.  Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery.

Authors:  Andrew M Baschnagel; Kurt D Meyer; Peter Y Chen; Daniel J Krauss; Rick E Olson; Daniel R Pieper; Ann H Maitz; Hong Ye; Inga Siiner Grills
Journal:  J Neurosurg       Date:  2013-08-23       Impact factor: 5.115

View more
  2 in total

1.  Clinical implementation of HyperArc.

Authors:  Felix H C Wong; Puleng A Moleme; Omer A Ali; Koki V Mugabe
Journal:  Phys Eng Sci Med       Date:  2022-04-11

2.  Long-Term Survival after Linac-Based Stereotactic Radiosurgery and Radiotherapy with a Micro-Multileaf Collimator for Brain Metastasis.

Authors:  Ryosuke Matsuda; Masatoshi Hasegawa; Tetsuro Tamamoto; Nobuyoshi Inooka; Mei Nikimoto; Tomoko Ochi; Toshiteru Miyasaka; Shigeto Hontsu; Kaori Yamaki; Sachiko Miura; Takayuki Morimoto; Takaaki Mitsui; Takanori Furuta; Shohei Yokoyama; Masashi Kotsugi; Shuichi Yamada; Ichiro Nakagawa; Young-Soo Park; Hiroyuki Nakase
Journal:  Curr Oncol       Date:  2022-08-24       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.